NuCana (NCNA) Non-Current Assets (2016 - 2025)
NuCana (NCNA) reported Non-Current Assets of $4.0 million for Q4 2025, up 22.8% on a YoY basis from $3.2 million in Q4 2024, and up 18.32% sequentially from $3.3 million in Q3 2025.
NuCana (NCNA) Non-Current Assets (2016 - 2025) Analysis & Trends
NuCana (NCNA) has 10 years of Non-Current Assets data on file, last reported at $4.0 million in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Assets rose 22.8% year-over-year to $4.0 million; the trailing twelve-month figure through Dec 2025 stood at $13.9 million (up 330.74% YoY), and the FY2025 full-year result was $3.9 million, up 22.22% from the prior year.
- Non-Current Assets climbed to $4.0 million in Q4 2025, from $3.3 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $11.7 million in Q3 2021 to a low of $3.1 million in Q1 2025.
- A 5-year average of $5.3 million and a median of $4.0 million in 2023 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets soared 50.99% in 2021 and plunged 50.5% in 2022, its largest moves.
- Tracing NCNA's Non-Current Assets over 5 years: stood at $7.9 million in 2021, then sank by 50.5% to $3.9 million in 2022, then fell by 11.39% to $3.5 million in 2023, then retreated by 7.07% to $3.2 million in 2024, then increased by 22.8% to $4.0 million in 2025.
- Business Quant data shows NCNA's Non-Current Assets at $4.0 million in Q4 2025, $3.3 million in Q3 2025, and $3.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 910.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.95 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 3.32 Mn |
| Mar 31, 2025 | 3.13 Mn |
| Dec 31, 2024 | 3.22 Mn |
| Sep 30, 2024 | 3.45 Mn |
| Jun 30, 2024 | 3.44 Mn |
| Mar 31, 2024 | 3.49 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Sep 30, 2023 | 4.21 Mn |
| Jun 30, 2023 | 4.21 Mn |
| Mar 31, 2023 | 4.10 Mn |
| Dec 31, 2022 | 3.91 Mn |
| Sep 30, 2022 | 7.34 Mn |
| Jun 30, 2022 | 7.26 Mn |
| Mar 31, 2022 | 7.86 Mn |
| Dec 31, 2021 | 7.90 Mn |
| Sep 30, 2021 | 11.69 Mn |
| Jun 30, 2021 | 8.23 Mn |
| Mar 31, 2021 | 8.14 Mn |